20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9614 | MERS-CoV-IN-1 | SARS-CoV | |
MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus.It is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS). | |||
T7766 | Remdesivir | GS-5734 | SARS-CoV , DNA/RNA Synthesis |
Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viru... | |||
T72231 | SARS-CoV-2/MERS Mpro-IN-2 | ||
SARS-CoV-2/MERS Mpro-IN-2 is a potent inhibitor of the main proteases of SARS-CoV-2 and MERS, demonstrating IC50 values of 0.21 and 0.07 µM, respectively. | |||
T72230 | SARS-CoV-2/MERS Mpro-IN-1 | ||
SARS-CoV-2/MERS Mpro-IN-1 is a potent inhibitor of the main proteases in SARS-CoV-2 and MERS, exhibiting IC50 values of 0.10 and 0.06 µM, respectively. | |||
T60085 | MM3122 | GTPL11533,MM-3122,Ac-GQFR-kbt | SARS-CoV |
MM3122 (MM-3122) is a selective type II transmembrane serine protease (TMPRSS2) inhibitor, IC50 = 0.34 nM. MM3122 effectively blocks TMPRSS2, thereby inhibiting the entry of SARS-CoV-2 and MERS-CoV into human cells. | |||
T8498 | EIDD-1931 | Beta-d-N4-hydroxycytidine | Virus Protease , HCV Protease , SARS-CoV , Topoisomerase |
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity.It inhibits replication of severe acute respiratory syndrome coronavirus (SARS-CoV) in Vero 76 cells, Middle East respiratory syndr... | |||
T60951 | Molnupiravir | EIDD-2801,Lagevrio,MK-4482 | SARS-CoV , Influenza Virus |
Molnupiravir (MK-4482) (EIDD-2801) is a prodrug of the ribonucleoside analog EIDD-1931 which is orally bioavailable. Molnupiravir can be used in COVID-19, seasonal and pandemic influenza research that has broad spectrum ... | |||
T3374 | Dihydrotanshinone I | DHTS,15,16-dihydrotanshinone I | SARS-CoV , ROS |
Dihydrotanshinone I (DHTS) is a natural compound extracted from Salvia miltiorrhiza Bunge used for treating of cardiovascular diseases. | |||
T6573 | E 64c | NSC 694279,EP 475,Loxistatin Acid | SARS-CoV , Cysteine Protease |
E 64c (EP 475) , a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor. | |||
T36652 | Anti-MERS-3A1 mAb | Anti-MERS-3A1 mAb | |
Anti-MERS-3A1 mAb (MERS-3A1) is a high-affinity human monoclonal IgG1 antibody derived from CHO cells. It effectively inhibits the interaction between the MERS-CoV spike protein and the DPP4 receptor[1]. | |||
T12836 | SARS-CoV-2-IN-1 | Others | |
SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively). | |||
T68674 | Vincapusine | ||
Vincapusine is a natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro. | |||
T78867 | WU-04 | SARS-CoV | |
WU-04 is a non-covalent inhibitor targeting the 3CLpro protein of SARS-CoV-2, demonstrating high inhibitory effects on 3CLpro from six SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Lambda, and Omicron) as well as two o... | |||
T72313 | SARS-CoV-2 3CLpro-IN-11 | ||
SARS-CoV-2 3CLpro-IN-11(11d) is a broad-spectrum antiviral compound that effectively inhibits the SARS-CoV-2 3CL protease, achieving an IC50 of 140 nM. Additionally, it exhibits inhibitory activity against SARS-CoV-1 and... | |||
T39334 | Remdesivir nucleoside monophosphate | ||
Remdesivir nucleoside monophosphate, a metabolite of Remdesivir, is a potent antiviral compound with nucleoside analogue characteristics. It exhibits effective antiviral activity against both SARS-CoV and MERS-CoV. | |||
T76669 | Anti-MERS-D12 mAb | ||
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12), a human monoclonal IgG1, specifically targets the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD). By directly binding to this region, it effec... | |||
T69547 | UAWJ9-36-3 | ||
UAWJ9-36-3 is a SARS-CoV-2 Protease inhibitor (IC50 = 54 nM). UAWJ9-36-3 showed potent binding and enzymatic inhibition against the Mpro's from SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-NL63, HCoV-229E, and HCoV-HK... | |||
T69548 | UAWJ9-36-1 | ||
UAWJ9-36-1 is a SARS-CoV-2 Protease inhibitor (IC50 = 51 nM). UAWJ9-36-1 showed potent binding and enzymatic inhibition against the Mpro's from SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-NL63, HCoV-229E, and HCoV-HK... | |||
T72312 | SARS-CoV-2 3CLpro-IN-10 | ||
SARS-CoV-2 3CLpro-IN-10(5d) is a potent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 value of 190 nM, and demonstrates varied efficiency against other coronaviruses with IC50 values of 790 nM for SARS-CoV... | |||
T79339 | NSC89641 | SARS-CoV | |
NSC89641 demonstrates potent inhibition of MERS-CoV M^pro, achieving an IC_50 value of less than 3.5 µM. Furthermore, it exerts significant inhibitory effects on SARS-CoV-2 M^pro enzymatic activity, with an IC_50 of 3.05... |